Top

Addiction Science & Clinical Practice

Published in:

Open Access 01-12-2019 | Research

Receipt of pharmacotherapy for alcohol use disorder by justice-involved women in the Veterans Health Administration

Authors: Emmeline Taylor, Christine Timko, Alex H. S. Harris, Mengfei Yu, Andrea K. Finlay

Published in: Addiction Science & Clinical Practice | Issue 1/2019

Abstract

Background

Alcohol use disorder (AUD) and unhealthy drinking are prevalent among women involved in the criminal justice system and women military veterans. Pharmacotherapy—including naltrexone, topiramate, acamprosate, and disulfiram—for AUD is one form of effective treatment that is associated with better health and criminal justice outcomes. The current study examined the association of justice involvement with receipt of pharmacotherapy for AUD, as well as other patient factors that may explain variation in receipt of pharmacotherapy for AUD among women veterans who receive care at Veterans Health Administration (VHA) facilities.

Methods

Using national VHA clinical records, we examined all women VHA patients who received an AUD diagnosis during an outpatient or inpatient visit in fiscal years (FY) 2014–2017. We compared patient characteristics by justice status, defined as contact with one of the VHA’s justice outreach programs, and used a mixed-effects logistic regression model to test whether justice involvement was independently associated with odds of receiving pharmacotherapy for AUD.

Results

Of 10,511 women veterans diagnosed with AUD in FY2017, 852 (8%) met our definition of justice-involved. Since FY2014, the percentage of women veterans who received pharmacotherapy for AUD increased (14–21%). Women justice-involved veterans and those who were homeless had higher odds of receiving pharmacotherapy for AUD (OR 1.29, CI 1.15–1.45; OR 1.35, CI 1.25–1.47). Women veterans age 55 or older or who were African-American had lower odds of receiving pharmacotherapy (OR 0.74, CI 0.67–0.82; OR 0.73, CI 0.68–0.79).

Conclusions

While women involved in the criminal justice system face many barriers to accessing health and social services, women justice-involved veterans had higher odds of receiving pharmacotherapy for AUD at VHA facilities compared to women veterans with no justice involvement. Legal mandates and supportive programming directed towards veterans in the criminal justice system may explain the higher rate of receipt of pharmacotherapy observed among justice-involved women veterans. Women veterans who are homeless may also have more opportunities to access and use pharmacotherapy for AUD compared to their housed counterparts.

Brewer-Smyth K, Pohlig R. Risk factors for women being under the influence of alcohol compared with other illicit substances at time of committing violent crimes. J Forensic Nurs. 2017;13:186–95. https://doi.org/10.1097/JFN.0000000000000177.CrossRefPubMed

Greenfeld LA, Snell TL. Women offenders. Washington, DC: Bureau of Justice Statistics; 1999. http://bjs.gov/content/pub/pdf/wo.pdf.

Binswanger IA, Merrill JO, Krueger PM, White MC, Booth RE, Elmore JG. Gender differences in chronic medical, psychiatric, and substance-dependence disorders among jail inmates. Am J Public Health. 2010;100:476–82. https://doi.org/10.2105/AJPH.2008.149591.CrossRefPubMedPubMedCentral

Center for Behavioral Health Statistics and Quality. Results from the 2017 national survey on drug use and health: detailed tables. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2018.

Hoggatt KJ, Williams EC, Der-Martirosian C, Yano EM, Washington DL. National prevalence and correlates of alcohol misuse in women veterans. J Subst Abuse Treat. 2015;52:10–6. https://doi.org/10.1016/j.jsat.2014.12.003.CrossRefPubMed

Sartor C, Mccutcheon V, Pommer N, Nelson E, Duncan A, Waldron M, Bucholz K, Madden P, Heath AC. Posttraumatic stress disorder and alcohol dependence in young women. J Stud Alcohol Drugs. 2010;71:810–8. https://doi.org/10.15288/jsad.2010.71.810.CrossRefPubMedPubMedCentral

Evans EA, Glover DL, Washington DL, Hamilton AB. Psychosocial factors that shape substance abuse and related mental health of women military veterans who use community-based services. Subst Use Misuse. 2018. https://doi.org/10.1080/10826084.2018.1441309.CrossRefPubMed

McCall JD, Tsai J. Characteristics and health needs of veterans in jails and prisons: what we know and do not know about incarcerated women. Womens Health Issues. 2018;28:172–80. https://doi.org/10.1016/j.whi.2017.10.009.CrossRefPubMed

Finlay AK, Binswanger IA, Smelson D, Sawh L, McGuire J, Rosenthal J, Blue-Howells J, Timko C, Blodgett JC, Harris AHS, Asch SM, Frayne S. Sex differences in mental health and substance use disorders and treatment entry among justice-involved veterans in the Veterans Health Administration. Med Care. 2015;53:105–11. https://doi.org/10.1097/MLR.0000000000000271.CrossRef

10.

Baser O, Chalk M, Rawson R, Gastfriend DR. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence. Am J Manag Care. 2011;17:222–34.

11.

Finigan MW, Perkins T, Zold-Kilbourn P, Parks J, Stringer M. Preliminary evaluation of extended-release naltrexone in Michigan and Missouri drug courts. J Subst Abuse Treat. 2011;41:288–93. https://doi.org/10.1016/j.jsat.2011.04.003.CrossRefPubMed

12.

Arbaizar B, Diersen-Sotos T, Gomez-Acebo I, Llorca J. Topiramate in the treatment of alcohol dependence: a meta-analysis. Actas espanolas de psiquiatria. 2010;38:8–12.PubMed

13.

Bouza C, Angeles M, Munoz A, Amate JM. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction. 2004;99:811–28. https://doi.org/10.1111/j.1360-0443.2004.00763.x.CrossRefPubMed

14.

Jonas DE, Amick HR, Feltner C, Bobashev G, Thomas K, Wines R, Kim MM, Shanahan E, Gass CE, Rowe CJ, Garbutt JC. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA. 2013;311:1889–900.CrossRef

15.

Kranzler HR, Van Kirk J. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol Clin Exp Res. 2001;25:1335–41.CrossRef

16.

Maisel N, Blodgett J, Wilbourne P, Humphreys K, Finney JW. Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: When are these medications most helpful? Addiction. 2013;108:275–93. https://doi.org/10.1111/j.1360-0443.2012.04054.x.CrossRefPubMed

17.

American Psychiatric Association. The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder. Washington, DC: American Psychiatric Association Publishing; 2018. https://doi.org/10.1176/appi.books.9781615371969.CrossRef

18.

The Management of Substance Use Disorders Work Group. VA/DOD clinical practice guideline for the management of substance use disorders. Washington, DC: US Department of Veterans Affairs and Department of Defense; 2015.

19.

Skinner MD, Lahmek P, Pham H, Aubin HJ. Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis. PLoS One. 2014;9:e87366.CrossRef

20.

Department of Veterans Affairs. Uniform Mental Health Services in VA Medical Centers and Clinics. VHA handbook 1160.1. Washington, DC: US Department of Veterans Affairs, Veterans Health Administration; 2008.

21.

Alemagno SA. Women in jail: Is substance abuse treatment enough? Am J Public Health. 2001;91:798–800.CrossRef

22.

Lewis C. Treating incarcerated women: gender matters. Psychiatr Clin North Am. 2006;29:773–89.CrossRef

23.

van Olphen J, Eliason MJ, Freudenberg N, Barnes M. Nowhere to go: how stigma limits the options of female drug users after release from jail. Subst Abuse Treat Prev Policy. 2009;4:1–10.CrossRef

24.

Harris AHS, Weisner C, Chalk M, Capoccia V, Chen C, Thomas CP. Specifying and pilot testing quality measures for the American Society of Addiction Medicine’s standards of care. J Addict Med. 2016;10:148–55. https://doi.org/10.1097/ADM.0000000000000203.CrossRefPubMedPubMedCentral

25.

Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–9.CrossRef

26.

Blue-Howells JH, Clark SC, van den Berk-Clark C, McGuire JF. The US Department of Veterans Affairs Veterans Justice Programs and the sequential intercept model: case examples in national dissemination of intervention for justice-involved veterans. Psychol Serv. 2013;10:48–53.CrossRef

27.

Thomas CP, Ritter GA, Harris AHS, Garnick DW, Freedman KI, Herbert B. Applying the American Society of Addiction Medicine performance measures in commercial health insurance and service data. J Addict Med. 2018;0:1–8.

28.

Hartwell SW, Deng X, Fisher W, Siegfriedt J, Roy-Bujnowski K, Johnson C, Fulwiler C. Predictors of accessing substance abuse services among individuals with mental disorders released from correctional custody. J Dual Diagn. 2013;9:11–22.CrossRef

29.

Martin BK, Clapp L, Alfers J, Beresford T. Adherence to court-ordered disulfiram at 15 months: a naturalistic study. J Subst Abuse Treat. 2004;26:233–6. https://doi.org/10.1016/S0740-5472(03)00208-3.CrossRefPubMed

30.

Department of Veterans Affairs. Sourcebook: women Veterans in the Veterans Health Administration, volume 3. Washington, DC: US Department of Veterans Affairs, Veterans Health Administration; 2014. https://www.womenshealth.va.gov/docs/Sourcebook_Vol_3_FINAL.pdf.

31.

Slattery M, Dugger M, Lamb T, Williams L. Catch, treat, and release: veteran treatment courts address the challenges of returning home. Subst Use Misuse. 2013;48:922–32. https://doi.org/10.3109/10826084.2013.797468.CrossRefPubMed

32.

Hartwell SW. Triple stigma: persons with mental illness and substance abuse problems in the criminal justice system. Crim Justice Policy Rev. 2004;15:84–99. https://doi.org/10.1177/0887403403255064.CrossRef

33.

Rubinsky AD, Chen C, Batki SL, Williams EC, Harris AH. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses. J Psychiatr Res. 2015;69:150–7.CrossRef

34.

Van Voorhis P, Wright EM, Salisbury E, Bauman A. Women’s risk factors and their contribution to existing risk/needs assessment: the current status of a gender-responsive supplement. Crim Justice Behav. 2010;37:261–88.CrossRef

35.

Tsai J, Rosenheck RA, Kane V. Homeless female U.S. veterans in a national supported housing program: comparison of individual characteristics and outcomes with male veterans. Psychol Serv. 2014;11:309–16. https://doi.org/10.1037/a0036323.CrossRefPubMed

36.

Rosenheck R, Gallup P, Frisman LK. Health care utilization and costs after entry into an outreach program for homeless mentally ill veterans. Hosp Community Psychiatry. 1993;44:1166–71.PubMed

37.

Greenberg GA, Rosenheck RA. Jail incarceration, homelessness, and mental health: a national study. Psychiatr Serv. 2008;59:170–7.CrossRef

38.

Williams EC, Gupta S, Rubinsky AD, Glass JE, Jones-Webb R, Bensley KM, Harris AHS. Variation in receipt of pharmacotherapy for alcohol use disorders across racial/ethnic groups: a national study in the U.S. Veterans Health Administration. Drug Alcohol Depend. 2017;178:527–33. https://doi.org/10.1016/j.drugalcdep.2017.06.011.CrossRefPubMed

39.

Keyes KM, Hatzenbuehler ML, McLaughlin KA, Link B, Olfson M, Grant BF, Hasin D. Stigma and treatment for alcohol disorders in the United States. Am J Epidemiol. 2010;172:1364–72. https://doi.org/10.1093/aje/kwq304.CrossRefPubMedPubMedCentral

40.

Arndt S, Acion L, White K. How the states stack up: disparities in substance abuse outpatient treatment completion rates for minorities. Drug Alcohol Depend. 2013;132:547–54. https://doi.org/10.1016/j.drugalcdep.2013.03.015.CrossRefPubMed

41.

Kimerling R, Pavao J, Greene L, Karpenko J, Rodriguez A, Saweikis M, Washington DL. Access to mental health care among women Veterans: Is VA meeting women’s needs? Med Care. 2015;53:97–104. https://doi.org/10.1097/MLR.0000000000000272.CrossRef

42.

Freudenberg N. Adverse effects of US jail and prison policies on the health and well-being of women of color. Am J Public Health. 2002;92:1895–9.CrossRef

43.

Spithoff S, Turner S, Gomes T, Martins D, Singh S. First-line medications for alcohol use disorders among public drug plan beneficiaries in Ontario. Can Fam Physician. 2017;63:277–83.

44.

Oslin D, Liberto JG, O’Brien J, Krois S, Norbeck J. Naltrexone as an adjunctive treatment for older patients with alcohol dependence. Am J Geriatr Psychiatry. 1997;5:324–32.CrossRef

45.

Satre D, Mertens JR, Areán PA, Weisner C. Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program. Addiction. 2004;99:1286–97.CrossRef

46.

Shahpesandy H, Pristásová J, Janíková Z, Mojzisová R, Kasanická V, Supalová O. Alcoholism in the elderly: a study of elderly alcoholics compared with healthy elderly and young alcoholics. Neuro Endocrinol Lett. 2006;27:651–7.PubMed

Title: Receipt of pharmacotherapy for alcohol use disorder by justice-involved women in the Veterans Health Administration
Authors: Emmeline Taylor
Christine Timko
Alex H. S. Harris
Mengfei Yu
Andrea K. Finlay
Publication date: 01-12-2019
Publisher: BioMed Central
Published in: Addiction Science & Clinical Practice / Issue 1/2019
Electronic ISSN: 1940-0640
DOI: https://doi.org/10.1186/s13722-018-0129-x

At a glance: The STEP trials

Springer Medicine

Receipt of pharmacotherapy for alcohol use disorder by justice-involved women in the Veterans Health Administration

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2019

Ask about smoking, not quitting: a chronic disease approach to assessing and treating tobacco use

Implementing alcohol use disorder pharmacotherapy in primary care settings: a qualitative analysis of provider-identified barriers and impact on implementation outcomes

HIV care provider perceptions and approaches to managing unhealthy alcohol use in primary HIV care settings: a qualitative study

Priming primary care providers to engage in evidence-based discussions about cannabis with patients

How to overcome political and legal barriers to the implementation of a drug consumption room: an application of the policy agenda framework to the Belgian situation

Asking about the last four drinking occasions on a tablet computer as a way to record alcohol consumption in Aboriginal and Torres Strait Islander Australians: a validation